Showing 15,561 - 15,580 results of 100,704 for search '(( 5 ((((ng decrease) OR (mean decrease))) OR (a decrease)) ) OR ( 5 point decrease ))', query time: 1.79s Refine Results
  1. 15561
  2. 15562
  3. 15563
  4. 15564
  5. 15565

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  6. 15566

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  7. 15567

    Data from paper "<b>Selectively vulnerable deep cortical layer 5/6 fast-spiking interneurons in Alzheimer’s Disease models </b><b><i>in vivo</i></b>", Papanikolaou et al., Neuron 2... by Amalia Papanikolaou (20974103)

    Published 2025
    “…These dysfunctions occurred alongside a deep layer-specific reduction in neuronal pentraxin 2 (NPTX2) within excitatory neurons, decreased GluA4 in PV-FSIs, and fewer excitatory synapses onto PV-FSIs. …”
  8. 15568
  9. 15569
  10. 15570
  11. 15571
  12. 15572
  13. 15573
  14. 15574
  15. 15575

    Image_5_COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective.TIF by Satoshi Nishiwaki (560641)

    Published 2021
    “…Similarly, the mean percentage change of reported results for each month in 2019 and 2020 was −5.1%, with the maximum of −27.4% observed in July 2020. …”
  16. 15576
  17. 15577
  18. 15578
  19. 15579
  20. 15580

    Selective C−H Activation of Haloalkanes using a Rhodiumtrispyrazolylborate Complex by Andrew J. Vetter (2349535)

    Published 2009
    “…By comparing the kinetic stabilities of a series of 1-chloroalkane activation products (C<sub>1</sub>−C<sub>5</sub>), it was found that the chlorine substituent dramatically decreases reductive elimination rates as the substitution is closer to the metal center. …”